InSilico Medicine Cayman TopCo valuation

3696 · HKEX · HKD

Compare InSilico Medicine Cayman TopCo
$30.60Change from previous close: −8.55%Absolute change: −$2.86

Close · November 20, 2026

Valuation

The average price target of 10 analysts is $76.70.

Data as of November 21, 2026

InSilico Medicine Cayman TopCo compared with similar companies

InSilico Medicine Cayman TopCo's Forward P/E: 19.9, −45% against the median of a group of 9 similar companies (36.1).

InSilico Medicine Cayman TopCo's metrics compared with similar companies
MetricInSilico Medicine Cayman TopCoMedian25th–75th percentileBand
Forward P/E19.936.126.0 – 45.4Low
Price/book4.644.642.59 – 7.27Middle
Price/sales150.318.47.40 – 43.6High
Gross margin87.9%77.3%49.8% – 84.4%High
Operating margin-6.9%14.0%-18.8% – 20.5%Middle
Net margin-220.3%3.8%-61.6% – 25.3%Low
ROE443.1%10.4%-1.8% – 35.7%High
Debt/equity0.040.160.05 – 0.41Low

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

Other metrics

Valuation multiples

Market cap
$20.31B
Enterprise value
$19.37B
P/E (trailing 12 months)
-6.48
PEG
1.06
EV/EBITDA
-3,038.0
EV/revenue
143.4

Profitability and growth

ROA
-1.4%
ROIC
10.9%
Revenue growth (year over year)
287.2%
Earnings growth (year over year)
-124.0%

Financial health

Total cash
$584.82M
Total debt
$19.66M
Current ratio
8.71
Quick ratio
8.65
Altman Z-Score
32.0
Piotroski F-Score
4.00

Dividends

Dividend yield
0.0%

Analysts and estimates

Average price target
$76.70
Median price target
$76.99
High price target
$100.02
Low price target
$50.01
Analysts with a price target
10
Consensus
Strong buy
Forward EPS
$1.74
EPS estimate, current year
$0.14

Shares and trading

Average volume
14.15M
Shares outstanding
586.56M
Float
502.94M
Institutional ownership
31.2%
Insider ownership
7.8%